Clinical Diagnostics

BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.

BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.

In this report, we take a deep dive into the clinical maturity of MTA / DP technologies, and benchmark how this activity varies across top industry players (biopharma, diagnostics developers, tools developers)

In this report, we take a deep dive into the clinical maturity of MTA / DP technologies, and benchmark how this activity varies across top industry players (biopharma, diagnostics developers, tools developers)

The DxBooks cover U.S. labs’ testing behaviors in the areas of oncology biomarkers, infectious disease diagnostics, and SARS-CoV-2 testing.

The DxBooks cover U.S. labs’ testing behaviors in the areas of oncology biomarkers, infectious disease diagnostics, and SARS-CoV-2 testing.

Liquid biopsies (LBx), which, to-date, have been used largely for genomic profiling and therapy selection, are finding new applications throughout the patient journey and within pharma research. To help predict the future state of the market, we have developed an evaluation framework to identify and assess areas of growth within the liquid biopsy market.

Liquid biopsies (LBx), which, to-date, have been used largely for genomic profiling and therapy selection, are finding new applications throughout the patient journey and within pharma research. To help predict the future state of the market, we have developed an evaluation framework to identify and assess areas of growth within the liquid biopsy market.

Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.

Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.

This report provides a summary of the current spatial biology market landscape as well as a forward-looking perspective of the spatial biology market from 2022 to 2027.

This report provides a summary of the current spatial biology market landscape as well as a forward-looking perspective of the spatial biology market from 2022 to 2027.

Next generation therapy trackers (TheraTrack) platform includes dynamic, up-to-date trackers of assets in development across cell therapies, viral gene therapies, nucleic acid based therapies, and antibody-drug conjugates.

Next generation therapy trackers (TheraTrack) platform includes dynamic, up-to-date trackers of assets in development across cell therapies, viral gene therapies, nucleic acid based therapies, and antibody-drug conjugates.